Supplementary Fig. S1. Amino acid sequence of the identified homologous proteins (matched peptides derived from rye are shown in Bold Red)
1. predicted protein
1 MATIPTTGSA LLRGSAALQR DGRSTRGRPS SAARPLPGRR TRSVVRASAK
51 DIAFDQASRS ALQAGVEKLA AAVGVTLGPR GRNVVLDEFG SPKVVNDGVT
101 IARAIELADP MENAGAALIR EVASKTNDSA GDGTTTASVL AREIIKLGLL
151 SVTSGANPVS IKKGIDKTVQ SLVEELEKKS RPVKGSGDIK AIAAISAGND
201 DFIGTMIAEA INKVGPDGVL SIESSSSFET TVEVEEGMEI DRGYISPQFV
251 TNSEKSVVEF ENARVLVTDQ KISSIKEILP LLEQTTQLRA PLLIIAEDVS
301 GEALATLVVN KLRGILNVAA IKAPGFGERR KALLQDIAIV TGAEFQAKDL
351 GQLIEQTTVE QLGIARKVTI SGSSTTIIAD VATKDEIQAR VAQLKRELSQ
401 TDSTYDSEKL AERIAKLSGG VAVIKVGAAT ETELEDRKLR IEDAKNATFA
451 AIEEGIVPGG GAAYVHLSTF VPAIKEKLDD PEERLGADII QKALVAPASL
501 IAHNAGVEGE VIVEKIKDSE WEFGYNAMTD KHENLVEAGV IDPAKVTRCA
551 LQNAASVAGM VLTTQAIVVE KPSKKAPAPA GMPQGMM
2. UTP--glucose-1-phosphate uridylyltransferase
1 MAAAAVAADS KIDGLRDAVA KLGEISENEK AGFISLVSRY LSGEAEQIEW
51 SKIQTPTDEV VVPYDTLAPP PEDLDAMKAL LDKLVVLKLN GGLGTTMGCT
101 GPKSVIEVRN GFTFLDLIVI QIESLNKKYG CSVPLLLMNS FNTHDDTQKI
151 VEKYSNSNIE IHTFNQSQYP RIVTEDFLPL PSKGQTGKDG WYPPGHGDVF
201 PSLNNSGKLD TLLSQGKEYV FVANSDNLGA IVDIKILNHL IHNQNEYCME
251 VTPKTLADVK GGTLISYEGR VQLLEIAQVP DEHVDEFKSI EKFKIFNTNN
301 LWVNLKAIKR LVDAEALKME IIPNPKEVDG VKVLQLETAA GAAIRFFEKA
351 IGINVPRSRF LPVKATSDLL LVQSDLYTLV DGYVIRNPAR VKPSNPSIEL
401 GPEFKKVANF LARFKSIPSI VELDSLKVSG DVSFGSGVVL KGNVTIAAKA
451 GVKLEIPDGA VLENKDINGP EDI
3. phosphoglycerate kinase, cytosolic
1 MATKRSVGTL GEADLKGKKV FVRADLNVPL DDAQKITDDT RIRASIPTIK
51 YLLEKGAKVI LASHLGRPKG VTPKFSLKPL VARLSELLGL EVVMAPDCIG
101 EEVEKLAAAL PDGGVLLLEN VRFYKEEEKN DPEFAKKLAS VADLYVNDAF
151 GTAHRAHAST EGVTKFLRPS VAGFLMQKEL DYLVGAVANP KKPFAAIVGG
201 SKVSSKIGVI ESLLAKVDIL ILGGGMIFTF YKAQGLAVGK SLVEEDKLEL
251 ATSLIETAKS KGVKLLLPTD VVVADKFAAD AESKIVPATA IPDGWMGLDV
301 GPDSIKTFAE ALDTTKTVIW NGPMGVFEFE KFAAGTDAIA KQLAELTGKG
351 VTTIIGGGDS VAAVEKAGLA DKMSHISTGG GASLELLEGK PLPGVLALDE
401 A
ATP synthase subunit beta, mitochondria
1 MASRRLLASL LRQSAQRGGG LISRSLGNSI PKSASRASSR ASPKGFLLNR
51 AVQYATSAAA PASQPSTPPK SGSEPSGKIT DEFTGAGSIG KVCQVIGAVV
101 DVRFDEGLPP ILTALEVLDN QIRLVLEVAQ HLGENMVRTI AMDGTEGLVR
151 GQRVLNTGSP ITVPVGRATL GRIINVIGEA IDERGPITTD HFLPIHREAP
201 AFVEQATEQQ ILVTGIKVVD LLAPYQRGGK IGLFGGAGVG KTVLIMELIN
251 NVAKAHGGFS VFAGVGERTR EGNDLYREMI ESGVIKLGEK QSESKCALVY
301 GQMNEPPGAR ARVGLTGLTV AEHFRDAEGQ DVLLFIDNIF RFTQANSEVS
351 ALLGRIPSAV GYQPTLATDL GGLQERITTT KKGSITSVQA IYVPADDLTD
401 PAPATTFAHL DATTVLSRQI SELGIYPAVD PLDSTSRMLS PHILGEDHYN
451 TARGVQKVLQ NYKNLQDIIA ILGMDELSED DKMTVARARK IQRFLSQPFH
501 VAEVFTGAPG KYVDLKESIN SFQGVLDGKY DDLSEQSFYM VGGIDEVIAK
551 AEKIAKESAA
4. predicted protein
1 MQAAAAVHRP HLLAASPLGA RASRRPSTVR MTLREDGPSV AIVGATGAVG
51 QEFLRVITAR DFPYRSLRLL ASERSAGKSI EFEGQDYTVQ DLAAPGAFEG
101 IDIALFSAGG GVSRAHAPAA VASGAVVVDN SSAYRMDPDV PLVIPEVNPE
151 AMADVRLGKG AIVANPNCST IICLMAVTPL HRHAKVKRMV VSTYQAASGA
201 GAAAMEELKL QTQEVLEGKP PTCNIFSQQY AFNIFSHNAP IVENGYNEEE
251 MKMVKETRKI WNDKDVRVTA TCIRVPTMRA HAESVNLQFE KPLDEDTARE
301 ILRAAPGVTI SDDRAANRFP TPLEVSDKDD VSVGRIRQDL SQDDNRGLEL
351 FVCGDQIRKG AALNAVQIAE MLLK
predicted protein
1 MVHGSLGKLA TRALSVAGKW QHQQLRRLNI HEYQGAELMG KFGINVPRGA
51 VVGSVQEVKE VLKNVFPSEK EIVVKSQILA GGRGLGTFKS GLKGGVHIVK
101 AEEAEGLAAK MLNQVLVTKQ TGPQGKVVGK VYLCEKMSLV NEMYFAITLD
151 RKTAGPLIIA CAEGGTSIED LAEKFPDKIV KVPVDVFKGI TDEDAAKVVD
201 GLAPKTADRQ SSIEQIKKLY ELFCKTDCTM LEINPLAETA DKKLVAADAK
251 LNFDDNAAFR QKEIFALRDT TQEDPREVAA AKADLNYIGL DGEIGCMVNG
301 AGLAMATMDI IKLHGGTPAN FLDVGGSASE GQVVEAFKIL TSDDRVKAIL
351 VNIFGGIMKC DVIASGIVNA AKQVDLKVPV VVRLEGTNVD QGKRILKESG
401 MTLITAEDLD DAAEKAVKAS VK
5. predicted protein
1 MVHGSLGKLA TRALSVAGKW QHQQLRRLNI HEYQGAELMG KFGINVPRGA
51 VVGSVQEVKE VLKNVFPSEK EIVVKSQILA GGRGLGTFKS GLKGGVHIVK
101 AEEAEGLAAK MLNQVLVTKQ TGPQGKVVGK VYLCEKMSLV NEMYFAITLD
151 RKTAGPLIIA CAEGGTSIED LAEKFPDKIV KVPVDVFKGI TDEDAAKVVD
201 GLAPKTADRQ SSIEQIKKLY ELFCKTDCTM LEINPLAETA DKKLVAADAK
251 LNFDDNAAFR QKEIFALRDT TQEDPREVAA AKADLNYIGL DGEIGCMVNG
301 AGLAMATMDI IKLHGGTPAN FLDVGGSASE GQVVEAFKIL TSDDRVKAIL
351 VNIFGGIMKC DVIASGIVNA AKQVDLKVPV VVRLEGTNVD QGKRILKESG
401 MTLITAEDLD DAAEKAVKAS VK
fructose-bisphosphate aldolase
1 MSAYCGKYKD ELIKNAAYIG TPGKGILAAD ESTGTIGKRF ASINVENVED
51 NRRALRELLF CTPGALQYLS GVILFEETLY QSTKGGKPFV DILKEGNVLP
101 GIKVDKGTIE LAGTNGETTT QGFDDLGKRC AKYYEAGARY AKWRAVLKIG
151 ATEPSQLSID QNAQGLARYA IICQENGLVP IVEPEILVDG PHDIDRCAYV
201 TEIVLAACYK ALNDQHVLLE GTLLKPNMVT PGSDAKKVAP EVIAEYTVRT
251 LQRTVPAAVP AIVFLSGGQS EEEATLNLNA MNKLQTKKPW NLSFSFGRAL
301 QQSTLKAWSG KAENEEKART AFLVRCKANS EATLGTYKGD ATLGEGASES
351 LHVKDYKY
6. Serpin-Z1B
1 MATTLATDVR LSIAHQTRFA LRLASTISSN PKSAASNAAF SPVSLHSALS
51 LLAAGAGSAT RDQLVATLGT GEVEGGHALA EQVVQFVLAD ASSAGGPRVA
101 FANGVFVDAS LLLKPSFQEL AVCKYKAETQ SVDFQTKAAE VTTQVNSWVE
151 KVTSGRIKNI LPSGSVDNTT KLVLANALYF KGAWTDQFDS YGTKNDYFYL
201 LDGSSVQTPF MSSMDDDQYI SSSDGLKVLK LPYKQGGDNR QFSMYILLPE
251 APGGLSSLAE KLSAEPDFLE RHIPRQRVAI RQFKLPKFKI SFGMEASDLL
301 KCLGLQLPFS DEADFSEMVD SPMPQGLRVS SVFHQAFVEV NEQGTEAAAS
351 TAIKMVPQQA RPPSVMDFIA DHPFLFLLRE DISGVVLFMG HVVNPLLSS
predicted protein
1 MASKGGNKGE GPAIGIDLGT TYSCVGVWQH DRVEIVANDQ GNRTTPSYVA
51 FTDTERLIGD AAKNQVAMNP TNTVFDAKRL IGRRFSDASV QSDMKMWPFK
101 VIPGAGDKPM IVVTYKGEEK TFSAEEISSM VLTKMREIAE AFLSTTINNA
151 VVTVPAYFND SQRQATKDAG VIAGLNVMRI INEPTAAAIA YGLDKKATST
201 GEKNVLIFDL GGGTFDVSIL TIEEGIFEVK STAGDTHLGG EDFDNRMVNH
251 FVQEFKRKNK KDISGNPRAL RRLRTACERA KRTLSSTAQT TIEIDSLYEG
301 IDFYATITRA RFEELNMDLF RKCMEPVEKC LRDAKMDKTQ VHEIVLVGGS
351 TRIPKVQQLL QDFFNGKELC KSINPDEAVA YGAAVQAAIL SGEGNQKVQD
401 LLLLDVTPLS LGLETAGGVM TTLIPRNTTI PTKKEQVFST YSDNQPGVLI
451 QVYEGERTRT KDNNLLGKFE LSGIPPAPRG VPQITVTFDI DANGILNVSA
501 EDKTTGQKNK ITITNDKGRL SKEEIERMVQ EAEKYKSEDE QVRHKVEARN
551 ALENYAYNMR NTVRDEKIAS KLPDDDKKKI EDSIEDAIKW LDGNQLAEAD
601 EFEDKMKELE SICNPIISKM YQGAGPGGAA GMDEDMPSGG AGAGGGSGAG
651 PKIEEVD
7. predicted protein
1 MSIARFSSTT HLVTLHTLGA TRQVTGRVLA KMSQGQQRRP SSDQAQAGGG
51 GGQGQGQGGG AVRYGDVFPA VAGGLAQKPV APQDAATMQS AENLVFGETI
101 KGGPAATMQS AAMRNERMGV VGHDQATDAT AEQGVSVSET RVPGGRIVTE
151 FVAGQAVGQY LAPDDAAGAG GAGGDDTKIT IGEALEAAGY SAGGRPVERS
201 DAAAIQAAEV RATGLDVNIP GGLAAQAQSA ADANAWAARD EEKAKLGDVL
251 TNASTKLVAD KEAEADDAAR VASAEIRNKD DKTVRPGGVA ASVAAAARLN
301 KQDV
14-3-3 protein
1 MSAPGELSRE ENVYMAKLAE QAERYEEMVE FMEKVAKTVD SEELTVEERN
51 LLSVAYKNVI GARRASWRII SSIEQKEESR GNEDRVTLIK EYRGKIETEL
101 SKICDGILKL LETHLVPSST APESKVFYLK MKGDYYRYLA EFKSGPERKD
151 AAENTMVAYK AAQDIALAEL APTHPIRLGL ALNFSVFYYE ILNSPDRACN
201 LAKQAFDEAI SELDTLSEES YKDSTLIMQL LRDNLTLWTS DITEDTAEEE
251 IREAPKHDSS EGQ
8. HSP70
1 MAKGEGPAIG IDLGTTYSCV GVWQHDRVEI IANDQGNRTT PSYVAFTDTE
51 RLIGDAAKNQ VAMNPTNTVF DAKRLIGRRF SDPSVQSDMK LWPFKVIPGP
101 ADKPMIVVNY KGEEKQFAAE EISSMVLIKM REIAEAFLGN SVKNAVVTVP
151 AYFNDSQRQA TKDAGAIAGL NVLRIINEPT AAAIAYGLDK KATSTGEKNV
201 LIFDLGGGTF DVSLLTIEEG IFEVKATAGD THLGGEDFDN RMVNHFVQEF
251 KRKHKKDITG NPRALRRLRT ACERAKRTLS STAQTTIEID SLYEGVDFYT
301 TITRARFEEL NMDLFRKCME PVEKCLRDAK MDKSTVHDVV LVGGSTRIPK
351 VQQLLQDFFN GKELCKSINP DEAVAYGASV QAAILSGEGN EKVQDLLLLD
401 VTPLSLGLET AGGVMTTLIP RNTTIPTKKE QVFSTYSDNQ PGVLIQVYEG
451 ERARTKDNNL LGKFELSGIP PAPRGVPQIT VCFDIDANGI LNVSAEDKTT
501 GQKNKITITN DKGRLSKEEI EKMVQEAERY KAEDEEHKKK VDAKNALENY
551 AYNMRNTVKD DKIASKLGAD DKKKVEEAIE GTISWLDANQ LAEADEFEDK
601 MKELEGICNP IIAKMYQGAA PDMGGGMGMD EDMPAGGGGA GPKIEEVD
9. predicted protein
1 MAAATARWLV LSLLVSALWA SSAAAAHETK WKAGAAVGGQ VVEKERRRVV
51 VESEAGTVTA TDVADAAGTV YRLQFITMDP GALFLPVQLH ADAVFYVHSG
101 RGKVTYIQEG GSETSSLEVQ RGDVYNLEQG SILYIQSYPN ATRERLRVYA
151 IFTSNAINCD DPSHPKSEAY SSVSNLLRGF DVKILRQGFG VSSGVVEAIT
201 SAKSPQSIIT YKPDQEKEES SNWTEEIFDA LWGDDSPLNK KKKKDKHKKK
251 DKKDDKSKSK TFNFYSGEPD VKNCFGWSKT MTNKDLQNLR GSDIGMFMVN
301 LTTGSMMGPH WNPKATEIAI VTHGSGIVQV VCPSIPSGAG GDHGHHDEGG
351 RGGGDHGHHD DGGRRRGDHG HHDEGGRRRG GHGHHDEGGN DGQEGIECKN
401 SVFGVKEGDV FVVPRFHPMA QLSFNNGSFV FVGFSTHMGE NNPQFLAGDH
451 SVLQVIGKEI VALALGQKNT TVVEKLLSAK SGSTIMACIS CAEELERKAE
501 QEEHEGGKGE REREREEEEE RERKQREEDE RKKREDDERK KREEEERKKR
551 EEEERKKREE EERERREEKG RKKREEEEAA RREQEEEEER RRREEEEGGG
601 GQGGGGGDDP REEEIQRRRE EEEEGGGRGD DPREEEERRR EEEGGRGGDD
651 PWEEEGGDWG DSTKYRAAMA TNLKKRYRGR KGSVFRSA
ras-related protein RIC2-like
1 MASGYRAEDD YDYLFKVVLI GDSGVGKSNL LSRFTRNEFS LESKSTIGVE
51 FATRSLQVDG KVVKAQIWDT AGQERYRAIT SAYYRGAVGA LLVYDVTRHA
101 TFENAERWLK ELRDHTDPNI VVMLVGNKSD LRHLVAVQTD EGKAFAERES
151 LYFMETSALE STNVEDAFAE VLTQIYRIVS KRAVEAGEDS ASGPGKGEKI
201 NMKDDVSAVK KGGCCSS
10. predicted protein
1 MAAATARWLV LSLLVSALWA SSAAAAHETK WKAGAAVGGQ VVEKERRRVV
51 VESEAGTVTA TDVADAAGTV YRLQFITMDP GALFLPVQLH ADAVFYVHSG
101 RGKVTYIQEG GSETSSLEVQ RGDVYNLEQG SILYIQSYPN ATRERLRVYA
151 IFTSNAINCD DPSHPKSEAY SSVSNLLRGF DVKILRQGFG VSSGVVEAIT
201 SAKSPQSIIT YKPDQEKEES SNWTEEIFDA LWGDDSPLNK KKKKDKHKKK
251 DKKDDKSKSK TFNFYSGEPD VKNCFGWSKT MTNKDLQNLR GSDIGMFMVN
301 LTTGSMMGPH WNPKATEIAI VTHGSGIVQV VCPSIPSGAG GDHGHHDEGG
351 RGGGDHGHHD DGGRRRGDHG HHDEGGRRRG GHGHHDEGGN DGQEGIECKN
401 SVFGVKEGDV FVVPRFHPMA QLSFNNGSFV FVGFSTHMGE NNPQFLAGDH
451 SVLQVIGKEI VALALGQKNT TVVEKLLSAK SGSTIMACIS CAEELERKAE
501 QEEHEGGKGE REREREEEEE RERKQREEDE RKKREDDERK KREEEERKKR
551 EEEERKKREE EERERREEKG RKKREEEEAA RREQEEEEER RRREEEEGGG
601 GQGGGGGDDP REEEIQRRRE EEEEGGGRGD DPREEEERRR EEEGGRGGDD
651 PWEEEGGDWG DSTKYRAAMA TNLKKRYRGR KGSVFRSA
beta1 proteasome-7D
1 MDAASSLMGG PSSADAPTDG EHRMGTTIVG VCYAGGVVLA ADSRTSTGMY
51 VANRASDKIS QLTDNVYVCR SGSAADTQVI SDYVRYFLHQ HTIQLGQPAT
101 VKVASNLVRL LAYQNKSMLQ AGMIVGGWDK YEGGQIYSVP LGGTILRQPF
151 AIGGSGSSYL YGLMDHEWKE GMTQEEAEKF VVKVVSLAIA RDGASGGVVR
201 TVTINEEGVK RSFHPGDKLP LWHEEMEPQN SLLDILAAGS SDAMVQ
predicted protein
1 MASRQDQASY RAGEAKTRAE EKTGYVVGAA QEKAREAKDT ASDAAGRAMD
51 KGRGAAEATK EKGYEAKDAS SDATGHAMDK GRGAAEATKE KGYEAKDKAA
101 GTAQQTGSYI GQTAEAAKQK AAGAAQYTID TARAGTQQTG NYIGQTAEAA
151 KQKAGAAAQY AMDTAVAGKD KTGSLLVQAG ETVKGAAVGA KDAVMNTIGM
201 GGGTNGSTDV PAKDTSTYKP GTRDY
11. peroxiredoxin
1 MPGLTIGDTV PNLELDSTHG KIRIHDYVGN GYVILFSHPG DFTPVCTTEL
51 AAMANYAKEF EKRGVKLLGI SCDDVQSHKE WTKDIEAYKP GSRVTYPIMA
101 DPDRSAIKQL NMVDPDEKDG QGQLPSRTLH IVGPDKVVKL SFLYPSCTGR
151 NMDEVVRAVD SLLTAAKHKV ATPANWKPGE CVVIAPGVSD EEAKKMFPQG
201 FETADLPSKK GYLRFTKV
basic endochitinase C
1 MRSLAVVVAV VATVAMAIGT AHGSVSSIIS HAQFDRMLLH RNDGACQAKG
51 FYTYDAFVAA ANAFPGFGAT GSTDARKRDV AAFLAQTSHE TTGGWATAPD
101 GAFAWGYCFK QERGAAADYC TPSAQWPCAP GKRYYGRGPI QLSHNYNYGP
151 AGRAIGVDLL RNPDLVATDP TVSFKTALWF WMTAQAPKPS SHAVITGKWS
201 PSGADRAAGR APGFGVITNI INGGLECGHG QDSRVADRIG FYKRYCDILG
251 VGYGDNLDCY NQRPFA
12. peroxiredoxin
1 MPGLTIGDTV PNLELDSTHG KIRIHDYVGN GYVILFSHPG DFTPVCTTEL
51 AAMANYAKEF EKRGVKLLGI SCDDVQSHKE WTKDIEAYKP GSRVTYPIMA
101 DPDRSAIKQL NMVDPDEKDG QGQLPSRTLH IVGPDKVVKL SFLYPSCTGR
151 NMDEVVRAVD SLLTAAKHKV ATPANWKPGE CVVIAPGVSD EEAKKMFPQG
201 FETADLPSKK GYLRFTKV
13. predicted protein
1 MASQLVESHR AGAEVLKGDE VCKKQTVELL EELGLPKGLF PMDDIEEVGY
51 NRESGFVWIL QKKKKEHTFK KINQTVSYDT EVTAFVEKGK IKKVTGVKIE
101 EVSLVEIYVD ESSADKVIVK TDTGLSDTHD AAAFALGE
14. 16.9 kDa class I heat shock protein 1
1 MSIVRRSNVF DPFADLWADP FDTFRSIVPA ISGGSSETAA FANARVDWKE
51 TPEAHVFKVD LPGVKKEEVK VEVEDGNVLV VSGERSREKE DKNDKWHRVE
101 RSSGKFVRRF RLPEDAKVEE VKAGLENGVL TVTVPKAEVK KPEVKAIEIS
151 G
15. 16.9 kDa class I heat shock protein 1
1 MSIVRRSNVF DPFADLWADP FDTFRSIVPA ISGGSSETAA FANARVDWKE
51 TPEAHVFKVD LPGVKKEEVK VEVEDGNVLV VSGERSREKE DKNDKWHRVE
101 RSSGKFVRRF RLPEDAKVEE VKAGLENGVL TVTVPKAEVK KPEVKAIEIS
151 G
16. immunophilin
1 MAKPGLLLCL LVVAAALLLV ASAKKSGDVS ALQIGVKYKP ESCSISAHKG
51 DRVKVHYRGT LTDGTVFDSS YERGDPIEFE LGTGQVIKGW DQGILGMCIG
101 EKRKLKIPSK LGYGDQGSPP TIPGGATLIF DTELVAVNGE PSSKSDEDVA
151 DSDL
17. dimeric alpha-amylase inhibitor
1 MLVATPIAAE YGAWSYNSGP WMCYPGQAFQ VPALPNCRPV LKLQCNGSQV
51 PEAVLRDCCQ QLAEISEWCR CGALYSMLDS MYKEHDVQEG QVGTTGAFPR
101 CRREVVRLTA ASITAVCRLP IVVDASGDGA YVCKGVATYP DA
18. cereal-type amylase inhibitor
1 MSEDCTPWTT TPITPLAGCR DYVEQQSCRI ETPGPPYLAK QQCCGELANI
51 PQQCRCQALR YFMGPKSRPD QSGLMELPGC PREVQMNFVK ILVTPGYCNL
101 TTVHNTPYCL TMEESQWS
19. glycine-rich RNA-binding protein
1 MADVEYRCFV GGLAWATDDQ SLQNAFSKYG DVIDSKIITD RETGRSRGFG
51 FVTFASDEAM RQAIEAMNGQ DLDGRNITVN EAQSRRSGGG GGGGFGGGGG
101 GYGGQRREGG GGGGYGGGGG GYRGGRSGGG GGYGSRDGGG YGGGGGGGYG
151 GSRGGSGGGN WRE
20. dimeric alpha-amylase inhibitor
1 MLVATPIAAE YGAWSYNSGP WMCYPGQAFQ VPALPNCRPV LKLQCNGSQV
51 PEAVLRDCCQ QLAEISEWCR CGALYSMLDS MYKEHDVQEG QVGTTGAFPR
101 CRREVVRLTA ASITAVCRLP IVVDASGDGA YVCKGVATYP DA
21. monomeric alpha-amylase inhibitor
1 SGPWSWCDPA TGYKVSALTG CRAMVKLQCV GSQVPEAVLR DCCQQLADIN
51 NEWCRCGDLS SMLRSVYQEL GVREGKEVLP GCRKEVMKLT AASVPEVCKV
101 PIPNPSGDRA GVCYWAAYPG V
22. monomeric alpha-amylase inhibitor
1 MWMKTVFWGL LLFMLVATTM AVEYGARSHN SGPWSWCDPA TGYKVSTLTG
51 CRAMVKLQCV GSQVPEAVLR DCCQQLANIN NEWCRCGDLS SMLRSVYQEL
101 GVREGKEVLP GCLKEVMKLT AASVPEVCKV PIPNPSGDRA GVCYWAAYPD
151 T
dimeric alpha-amylase inhibitor
1 MLVATPIAAE YGAWSYNSGP WMCYPGQAFQ VPALPNCRPV LKLQCNGSQV
51 PEAVLRDCCQ QLAEISEWCR CGALYSMLDS MYKEHDVQEG QVGTTGAFPR
101 CRREVVRLTA ASITAVCRLP IVVDASGDGA YVCKGVATYP DA
23. Early-methionine-labelled polypeptide
1 MASGQQERSQ LDRKAREGET VVPGGTGGTN LQAQENLAEG RSRGGQTRKE
51 QMGEEGYREM GRKGGLSTMD ESGGERAARE GIDIDESKFK TKS
24. xylanase inhibitor
1 PQFTQSMQYT PLVTKGGSPA HYISLKSIKV DNTGVTVSQS AFATGGVMLS
51 TRLPYALLRR DVYRPLVDAF TKALAAQPAN GAPVARAVQP VAPFGVCYDT
101 KTLGNNLGGY AVPNVLLALD GGGEWAMTGK NSMVDVRPGT ACVAFVEMKG
151 AEAGDGRAPA VILGGAQMED FVLDFDMEKK RLGFTRLPHF TGCGSA
25. elongation factor Tu
1 MAKEKFQRNK PHVNVGTIGH VDHGKTTLTA AIATVLSKKF GGEAKAYDQI
51 DAAPEEKARG ITINTAHVEY ETAGRHYAHV DCPGHADYVK NMITGAAQMD
101 GAILVCSAAD GPMPQTREHI LLARQVGVPY IIVFLNKCDM VDDEELLELV
151 EMEVRELLAK YDFPGDDTPI IRGSAKLALE GDQSDKGEAA ILRLAEALDS
201 YIPTPERAVD GAFAMPVEDV FSISGRGTVV TGRIERGIIK VGEEIEIVGI
251 RDTQKTIVTG VEMFRKLLDQ GQAGDNVGLL LRGTKREDVE RGQVLCKPGS
301 IKPHTHFTAE VYVLSKDEGG RHTPFFNNYR PQFYFRTTDV TGSIELPADK
351 EMVMPGDNVS ITVKLIAPIA MEEGLRFAIR EGGRTVGAGV VAKIIA
predicted protein
1 MAAKDVVFGG EARARMVEGV NILANAVKVT LGPKGRNVVL ERSFGAPTVT
51 KDGVSVAKEI ELKDKLQNMG AQLVKEVASK TNDIAGDGTT TATVLAQAIV
101 REGAKYVAAG LNPMDLKRGI DKAVAALVEE LKKQSKATTT SKEIAQVGSI
151 SANSDESVGS IIAEAMDKVG KEGVITVEEG KSLANELDVV EGMQFDRGYL
201 SPYFINNPEK QVALLDNPFV LLFDKKISNI RDLLPTLEAV AKAGRPLLII
251 AEDVEGEALA TLVVNTIRGI LKVVAVKAPG FGDRRKAMLE DIAILTGGKV
301 IAEEVGLALD KVTLEDLGQA VRIEIGKENT TIIDGAGQAA EIE
26. predicted protein
1 MAAKDVVFGG EARARMVEGV NILANAVKVT LGPKGRNVVL ERSFGAPTVT
51 KDGVSVAKEI ELKDKLQNMG AQLVKEVASK TNDIAGDGTT TATVLAQAIV
101 REGAKYVAAG LNPMDLKRGI DKAVAALVEE LKKQSKATTT SKEIAQVGSI
151 SANSDESVGS IIAEAMDKVG KEGVITVEEG KSLANELDVV EGMQFDRGYL
201 SPYFINNPEK QVALLDNPFV LLFDKKISNI RDLLPTLEAV AKAGRPLLII
251 AEDVEGEALA TLVVNTIRGI LKVVAVKAPG FGDRRKAMLE DIAILTGGKV
301 IAEEVGLALD KVTLEDLGQA VRIEIGKENT TIIDGAGQAA EIE
histone H4
1 MSWQAYVDDH LLCDIEGQHL SAAAIVGHDG SVWAQSENFP ELKPEEVAGM
51 IKDFDEPGTL APTGLFVGGT KYMVIQGEPG VVIRGKKGTG LGKGGAKRHR
101 KVLRDNIQGI TKPAIRRLAR RGGVKRISGL IYEETRGVLK IFLENVIRDA
151 VTYTEHARRK TVTAMDVVYA LKRQGRTLYG FGG
27. subtilisin-chymotrypsin inhibitor CI-1A
1 MSSMEGSVLK YPEPTEGSIG ASSAKTSWPE VVGMSAEKAK EIILRDKPNA
51 QVEVIPVDAM VHLNFDPNRV FVLVAVARTP TVG
elongation factor Tu
1 MAKEKFQRNK PHVNVGTIGH VDHGKTTLTA AIATVLSKKF GGEAKAYDQI
51 DAAPEEKARG ITINTAHVEY ETAGRHYAHV DCPGHADYVK NMITGAAQMD
101 GAILVCSAAD GPMPQTREHI LLARQVGVPY IIVFLNKCDM VDDEELLELV
151 EMEVRELLAK YDFPGDDTPI IRGSAKLALE GDQSDKGEAA ILRLAEALDS
201 YIPTPERAVD GAFAMPVEDV FSISGRGTVV TGRIERGIIK VGEEIEIVGI
251 RDTQKTIVTG VEMFRKLLDQ GQAGDNVGLL LRGTKREDVE RGQVLCKPGS
301 IKPHTHFTAE VYVLSKDEGG RHTPFFNNYR PQFYFRTTDV TGSIELPADK
351 EMVMPGDNVS ITVKLIAPIA MEEGLRFAIR EGGRTVGAGV VAKIIA
28. triosephosphate isomerase
1 MGRKFFVGGN WKCNGTVSQV ETIVNTLNAG QIASPDVVEV VVSPPYVFLP
51 TVKDKLRPEI QVAAQNCWVK KGGAFTGEVS AEMLVNLGIP WVILGHSERR
101 SLLAESSEFV GEKVAYALAQ GLKVIACVGE TLEQREAGST MEVVAEQTKA
151 IADKIKDWTN VVVAYEPVWA IGTGKVASPA QAQEVHANLR DWLKTNVSPE
201 VAESTRIIYG GSVTGASCKE LAAQPDVDGF LVGGASLKPE FIDIINAATV
251 KSA
subtilisin-chymotrypsin inhibitor CI-1A
1 MSSMEGSVLK YPEPTEGSIG ASSAKTSWPE VVGMSAEKAK EIILRDKPNA
51 QVEVIPVDAM VHLNFDPNRV FVLVAVARTP TVG
29. predicted protein
1 MSRLMAAMLL GGARVASATA LTGNTAVKAI PRPCFLAPRP HAASWSPICM
51 QTAPRSSQAY NNAPDDRRDV KDKYRGAAEQ AKDATGDAKE SAKGQASRMA
101 DETKDKAGDA AQRASQMTDK AKHETKETAS QAADKAGEMK DRAKETAEEA
151 AEKASRMTEK AKHETKETAS QAADKAGEMK ERAKETTGQA MDKAKETAGA
201 AKEKTAEVAE GAMDRAGEAK DRAAEGTRSA GEKVAELTKE GASKVAETAQ
251 AIGEKAKQAA QGAWDATKGA AQGVKEKVVS ESTTEEHSTW DDVEAATKER
301 DRIAQEERKR QAREKGAGLP
30. histone H4
1 MSWQAYVDDH LLCDIEGQHL SAAAIVGHDG SVWAQSENFP ELKPEEVAGM
51 IKDFDEPGTL APTGLFVGGT KYMVIQGEPG VVIRGKKGTG LGKGGAKRHR
101 KVLRDNIQGI TKPAIRRLAR RGGVKRISGL IYEETRGVLK IFLENVIRDA
151 VTYTEHARRK TVTAMDVVYA LKRQGRTLYG FGG
1